High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results

被引：22
|
作者：
Carella, Angelo Michele [1 ]
Bellei, Monica [2 ]
Brice, Pauline [3 ]
Gisselbrecht, Christian [3 ]
Visani, Giuseppe [4 ]
Colombat, Philippe [5 ]
Fabbiano, Francesco [6 ]
Donelli, Amedea [2 ]
Luminari, Stefano [2 ]
Feugier, Pierre [7 ]
Browett, Peter [8 ]
Hagberg, Hans [9 ,10 ,11 ]
Federico, Massimo [2 ]
机构：
[1] AOU San Martino, Div Ematol, I-16132 Genoa, Italy
[2] Univ Modena, Dip Oncol & Ematol, I-41100 Modena, Italy
[3] Hop St Louis, Inst Hematol, Paris, France
[4] Osped San Salvatore, Div Ematol, Pesaro, Italy
[5] Ctr Hop Bretonneau, Serv Oncol Med & Malad Sang, Tours, France
[6] Osped Cervello, Div Ematol, Palermo, Italy
[7] Univ Hosp Nancy, Dep Hemato Internal Med, Nancy, France
[8] Univ Auckland, Lab Med, Auckland 1, New Zealand
[9] Uppsala Univ, Dept Oncol, Uppsala, Sweden
[10] Uppsala Univ, Dept Radiol, Uppsala, Sweden
[11] Uppsala Univ, Dept Clin Immunol, Uppsala, Sweden
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 01期
关键词：
PROGNOSTIC SCORE; CHEMOTHERAPY; DISEASE; RISK;
D O I：
10.3324/haematol.13484
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：146 / 148
页数：3
相关论文
共 50 条
  • [41] Idiotype Immunization Following High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Costello, Caitlin L.
    Holman, Peter
    de Magalhaes-Silverman, Margarida
    Corringham, Sue
    Castro, Januario E.
    Ball, Edward D.
    BLOOD, 2011, 118 (21) : 1724 - 1724
  • [42] Effect of front-line therapy with either high-dose therapy and autologous stem cell rescue (HDT/ASCR) or dose-intensive therapy (R-Hypercvad) on outcome in mantle cell lymphoma (MCL).
    Feldman, T.
    Mato, A. R.
    Zielonka, T.
    Masood, A.
    Goldberg, S.
    Rowley, S. D.
    Donato, M.
    Siegel, D. S.
    Pecora, A.
    Goy, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] A randomized EPOCH vs. CHOP front-line therapy for aggressive non-Hodgkin's lymphoma patients: Long-term results
    Khaled, HM
    Zekri, ZK
    Mokhtar, N
    Ali, NM
    Darwish, T
    Elattar, I
    Gaafar, R
    Moawad, MS
    ANNALS OF ONCOLOGY, 1999, 10 (12) : 1489 - 1492
  • [44] High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review
    Reljic, T.
    Kumar, A.
    Djulbegovic, B.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2015, 50 (08) : 1069 - 1074
  • [45] EFFECT OF DURATION OF FIRST REMISSION ON LONG-TERM OUTCOME OF HODGKIN LYMPHOMA PATIENTS UNDERGOING HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (HD-ASCT)
    Gerrie, A. S.
    Power, M. M.
    Savage, K. J.
    Shepherd, J. D.
    Connors, J. M.
    ANNALS OF ONCOLOGY, 2011, 22 : 168 - 168
  • [46] Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy
    Brandt, Juliane
    Dietrich, Sascha
    Meissner, Julia
    Neben, Kai
    Ho, Anthony D.
    Witzens-Harig, Mathias
    LEUKEMIA & LYMPHOMA, 2010, 51 (11) : 2012 - 2020
  • [47] Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Dahi, Parastoo B.
    Tamari, Roni
    Devlin, Sean M.
    Maloy, Molly
    Bhatt, Valkal
    Scordo, Michael
    Goldberg, Jenna
    Zelenetz, Andrew D.
    Hamlin, Paul A.
    Matasar, Matthew J.
    Maragulia, Jocelyn
    Giralt, Sergio A.
    Perales, Miguel-Angel
    Moskowitz, Craig H.
    Sauter, Craig S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (12) : 2004 - 2009
  • [48] High-dose chemotherapy (HDCT) and autologous hematopoietic stem cell transplantation (AHSCT) does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: A comparison of conventional therapy alone versus conventional therapy followed by AHSCT.
    Forrest, DL
    Heemskerk, L
    Hogge, D
    Lavoie, J
    Le, A
    Nantel, S
    Nevill, T
    Shepherd, J
    Smith, C
    Song, K
    Sutherland, H
    Toze, C
    Voss, N
    Gascoyne, R
    Connors, J
    BLOOD, 2003, 102 (11) : 116A - 117A
  • [49] Long-Term Clinical and Molecular Remissions in Patients with Follicular Lymphoma (FL) Following High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT)
    Metzner, Bernd
    Rosien, Bernd
    Casper, Jochen
    Kohne, Claus-Henning
    Kraemer, Doris M.
    Mueller, Thomas H.
    Renzelmann, Andrea
    Thole, Ruth
    Pott, Christiane
    BLOOD, 2017, 130
  • [50] High-dose therapy with purged autologous stem cell transplantation (ASCT) as firstline therapy for follicular lymphoma.
    Wattad, M
    Lange, E
    Erbers, S
    Balleisen, L
    Heit, W
    BLOOD, 2000, 96 (11) : 376B - 376B
12345